A New Ca-Antagonist, Azelnidipine, Reduced Blood Pressure During Exercise Without Augmentation of Sympathetic Nervous System in Essential Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

A New Ca-Antagonist, Azelnidipine, Reduced Blood Pressure During Exercise Without Augmentation of Sympathetic Nervous System in Essential Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial

Published:1999-02 Issue:2 Volume:33 Page:186-192
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Arita Mikio,Hashizume Toshikazu,Tanigawa Koji,Yamamoto Hiroyuki,Nishio Ichiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference29 articles.

1. ASSESSMENT OF LEFT-VENTRICULAR MASS AND ITS RESPONSE TO ANTIHYPERTENSIVE TREATMENT

2. Exercise systolic blood pressure: A powerful determinant of increased left ventricular mass in patients with hypertension

3. EFFECT OF TEMOCAPRIL ON HAEMODYNAMIC AND HUMORAL RESPONSES TO EXERCISE IN PATIENTS WITH MILD ESSENTIAL HYPERTENSION

4. National High Blood Pressure Education Program Working Group report on ambulatory blood pressure monitoring

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limonin alleviates macro- and micro-vascular complications of metabolic syndrome in rats: A comparative study with azelnidipine;Phytomedicine;2018-04

2. Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders;Expert Review of Cardiovascular Therapy;2014-12

3. Azelnidipine and Amlodipine: A Comparison of Their Effects and Safety in a Randomized Double-Blinded Clinical Trial in Chinese Essential Hypertensive Patients;Clinical and Experimental Hypertension;2010-10

4. Continuous hypertension and tachycardia after resection of a hemangioblastoma behind the dorsal medulla oblongata: relationship to sympathetic overactivity at the neurogenic vasomotor center;Journal of Neurosurgery;2010-08

5. A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study;Pharmaceuticals;2010-01-19